Medicare Enrolled
Dr. Gregory Hoang, MD
Hematology & Oncology · Palm Bay, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hoang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hoang? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hoang
Dr. Gregory Hoang is a hematology & oncology in Palm Bay, FL, with 20 years in practice. Based on federal Medicare data, Dr. Hoang performed 60,898 Medicare services across 1,569 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hoang received a total of $33,242 from 99 pharmaceutical and/or device companies across 1381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hoang is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 13% volume in FL$ $33,242 industry payments
Medicare Practice Summary
Medicare Utilization ↗60,898
Medicare services
Top 13% in FL for hematology & oncology
1,569
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,045 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 15,750 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 15,420 | $18 | $70 |
| Pembrolizumab injection (Keytruda) | 11,000 | $43 | $147 |
| Anti-nausea injection (fosaprepitant) | 8,100 | $0 | $6 |
| Dexamethasone injection (steroid) | 2,760 | $0 | $3 |
| Iron infusion (Monoferric) | 1,900 | $17 | $74 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,190 | $1 | $122 |
| Anti-nausea injection (ondansetron/Zofran) | 640 | $0 | $4 |
| Complete blood count (CBC) with differential | 520 | $8 | $35 |
| Office visit, established patient (20-29 min) | 490 | $64 | $180 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 357 | $22 | $152 |
| Office visit, established patient (30-39 min) | 347 | $98 | $224 |
| Administration of chemotherapy into vein, 1 hour or less | 332 | $100 | $686 |
| Blood draw (venipuncture) | 265 | $8 | $19 |
| Drug injection, under skin or into muscle | 261 | $11 | $93 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 178 | $55 | $270 |
| Infusion, normal saline solution , 1000 cc | 171 | $2 | $19 |
| Administration of chemotherapy into vein, each additional hour | 144 | $22 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 137 | $49 | $304 |
| Injection of additional new drug or substance into vein | 135 | $12 | $105 |
| Injection, diphenhydramine hcl, up to 50 mg | 116 | $1 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 108 | $25 | $249 |
| Hospital follow-up visit, moderate complexity | 92 | $63 | $157 |
| Administration of additional new drug or substance into vein, 1 hour or less | 84 | $50 | $334 |
| New patient office visit (45-59 min) | 72 | $124 | $420 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 57 | $135 | $3,938 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 45 | $23 | $141 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 45 | $3 | $15 |
| Initial hospital admission, moderate complexity | 44 | $103 | $297 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 41 | $16 | $97 |
| Drawing of blood for a medical problem | 35 | $62 | $330 |
| Irrigation of implanted venous access drug delivery device | 28 | $18 | $111 |
| New patient office visit (30-44 min) | 18 | $81 | $230 |
| Office visit, established patient (10-19 min) | 16 | $29 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
30.3% high complexity
66.3% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$33,242
Total received (2018-2024)
Avg $4,749/year across 7 years
Top 18% in FL for hematology & oncology
99
Companies
1,381
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,107 (90.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,778 (5.3%)
Other
Charitable contributions, space rental, and other categories
$1,357 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$6,236
2023$5,937
2022$6,752
2021$6,324
2020$2,656
2019$2,715
2018$2,623
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$3,238
E.R. Squibb & Sons, L.L.C.
$2,123
AstraZeneca Pharmaceuticals LP
$2,039
PFIZER INC.
$1,857
Amgen Inc.
$1,666
Janssen Biotech, Inc.
$1,520
Incyte Corporation
$1,382
Celgene Corporation
$1,295
Merck Sharp & Dohme LLC
$1,237
Astellas Pharma US Inc
$1,136
Genentech USA, Inc.
$1,114
Seagen Inc.
$1,020
GENZYME CORPORATION
$951
Daiichi Sankyo Inc.
$775
Lilly USA, LLC
$769
Regeneron Healthcare Solutions, Inc.
$571
GlaxoSmithKline, LLC.
$530
Merck Sharp & Dohme Corporation
$514
Kite Pharma, Inc.
$453
Takeda Pharmaceuticals U.S.A., Inc.
$444
Gilead Sciences, Inc.
$422
ABBVIE INC.
$352
Ipsen Biopharmaceuticals, Inc
$344
Eisai Inc.
$335
Pharmacyclics LLC, An AbbVie Company
$308
Exelixis Inc.
$299
JAZZ PHARMACEUTICALS INC.
$285
Pharmacosmos Therapeutics Inc.
$266
EISAI INC.
$259
Bayer HealthCare Pharmaceuticals Inc.
$257
Alexion Pharmaceuticals, Inc.
$256
BeiGene USA, Inc.
$241
Karyopharm Therapeutics Inc.
$238
Mirati Therapeutics, Inc.
$224
Boehringer Ingelheim Pharmaceuticals, Inc.
$204
ARRAY BIOPHARMA INC
$189
EMD Serono, Inc.
$173
Novocure Inc.
$172
Janssen Products, LP
$170
NOVARTIS PHARMACEUTICALS CORPORATION
$167
ADC Therapeutics America, Inc.
$166
Pharmacyclics LLC, an AbbVie Company
$147
Bayer Healthcare Pharmaceuticals Inc.
$142
MorphoSys, US Inc.
$140
TAIHO ONCOLOGY, INC.
$140
Kyowa Kirin, Inc.
$129
Seattle Genetics, Inc.
$126
AVEO Pharmaceuticals, Inc.
$122
SOBI, INC
$113
SANOFI-AVENTIS U.S. LLC
$100
Janssen Scientific Affairs, LLC
$95
Rigel Pharmaceuticals, Inc.
$90
Sumitomo Pharma America, Inc.
$88
Taiho Oncology, Inc.
$87
Global Blood Therapeutics, Inc.
$85
G1 Therapeutics, Inc.
$83
PharmaEssentia USA Corporation
$79
SERVIER PHARMACEUTICALS LLC
$73
PUMA BIOTECHNOLOGY, INC.
$68
TESARO, Inc.
$66
Clovis Oncology, Inc.
$65
Alnylam Pharmaceuticals Inc.
$61
TerSera Therapeutics LLC
$56
Helsinn Therapeutics (U.S.), Inc.
$56
Janssen Pharmaceuticals, Inc
$55
Puma Biotechnology, Inc.
$54
Myovant Sciences Inc.
$53
Heron Therapeutics, Inc.
$52
AbbVie, Inc.
$51
Epizyme, Inc.,
$51
Dova Pharmaceuticals
$48
Mylan Institutional Inc.
$47
Sobi, Inc
$40
Stemline Therapeutics Inc.
$39
EUSA Pharma (US) LLC
$38
SpringWorks Therapeutics, Inc.
$36
Dendreon Pharmaceuticals LLC
$34
Deciphera Pharmaceuticals Inc.
$30
Legend Biotech USA Inc.
$29
Genmab U.S., Inc.
$29
Verity Pharmaceuticals Inc.
$28
Acceleron Pharma, Inc.
$28
AMAG Pharmaceuticals, Inc.
$26
Apellis Pharmaceuticals, Inc.
$25
Fortovia Therapeutics, Inc.
$25
Sun Pharmaceutical Industries Inc.
$24
Blueprint Medicines Corporation
$24
TG THERAPEUTICS, INC.
$24
ACCORD HEALTHCARE, INC.
$20
Servier Pharmaceuticals LLC
$20
Emmaus Medical, Inc.
$20
AbbVie Inc.
$19
CTI BioPharma Corp.
$18
Advanced Accelerator Applications
$18
Agios Pharmaceuticals, Inc.
$15
Verastem, Inc.
$15
Octapharma USA, Inc.
$14
Sirtex Medical Inc
$11
Organon LLC
$10
Top 3 companies account for 22.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CERDELGA · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Empaveli · Endari · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · FULPHILA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRBETRIQ · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONIVYDE · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Optune · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · SUTENT · Soltamox · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · Tecentriq Hybreza · Tibsovo · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYKADIA · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $55 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
18
Per 100K population
2.9
County median income
$75,817
Nearest hospital
PALM BAY HOSPITAL
8.5 mi
8.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hoang is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), and high industry engagement (low-engagement, top 18%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hoang experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Hoang performed 15,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hoang receive payments from pharmaceutical companies?
Yes. Dr. Hoang received a total of $33,242 from 99 companies across 1,381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hoang's costs compare to other hematology & oncologys in Palm Bay?
Dr. Hoang's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hoang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Palm Bay
Browse hematology & oncologys in Palm Bay ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology